annb0t
Top 20
Immutep Limited
Media Release
Final resultsfrom Part C of thePhase II TACTI-002 trial in 2nd line head and neck squamous cell carcinoma patients to be presented
SYDNEY, AUSTRALIA, April 26, 2023 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutepâ or âthe Companyâ), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces two abstracts have been selected for poster presentation at the upc...
>>> Read more: Immutep Announces Presentation of New TACTI-002 Data at the 2023 ASCO Annual Meeting
Media Release
Final resultsfrom Part C of thePhase II TACTI-002 trial in 2nd line head and neck squamous cell carcinoma patients to be presented
SYDNEY, AUSTRALIA, April 26, 2023 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutepâ or âthe Companyâ), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces two abstracts have been selected for poster presentation at the upc...
>>> Read more: Immutep Announces Presentation of New TACTI-002 Data at the 2023 ASCO Annual Meeting
